Adimmune Corp EBITDA vs. Price To Earning

4142 Stock  TWD 20.70  0.55  2.59%   
Considering Adimmune Corp's profitability and operating efficiency indicators, Adimmune Corp may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Adimmune Corp's ability to earn profits and add value for shareholders.
For Adimmune Corp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Adimmune Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Adimmune Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Adimmune Corp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Adimmune Corp over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Adimmune Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adimmune Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adimmune Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Adimmune Corp Price To Earning vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Adimmune Corp's current stock value. Our valuation model uses many indicators to compare Adimmune Corp value to that of its competitors to determine the firm's financial worth.
Adimmune Corp is number one stock in ebitda category among its peers. It also is number one stock in price to earning category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Adimmune Corp's earnings, one of the primary drivers of an investment's value.

Adimmune Price To Earning vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Adimmune Corp

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
254.89 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Adimmune Corp

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
(7.22) X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

Adimmune Price To Earning Comparison

Adimmune Corp is currently under evaluation in price to earning category among its peers.

Adimmune Corp Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Adimmune Corp, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Adimmune Corp will eventually generate negative long term returns. The profitability progress is the general direction of Adimmune Corp's change in net profit over the period of time. It can combine multiple indicators of Adimmune Corp, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Adimmune Corporation manufactures and sells human vaccines in Taiwan. Adimmune Corporation was founded in 1965 and is based in Taichung City, Taiwan. ADIMMUNE CORPORATION operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange. It employs 384 people.

Adimmune Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Adimmune Corp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Adimmune Corp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Adimmune Corp's important profitability drivers and their relationship over time.

Use Adimmune Corp in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adimmune Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adimmune Corp will appreciate offsetting losses from the drop in the long position's value.

Adimmune Corp Pair Trading

Adimmune Corp Pair Trading Analysis

The ability to find closely correlated positions to Adimmune Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adimmune Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adimmune Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adimmune Corp to buy it.
The correlation of Adimmune Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adimmune Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adimmune Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adimmune Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Adimmune Corp position

In addition to having Adimmune Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Junk Bonds Funds Thematic Idea Now

Junk Bonds Funds
Junk Bonds Funds Theme
Funds or Etfs that invest most of their assets into speculative (junk) bonds or to other fixed income instruments with interest rates 3 to 4 percentage points above government issues. The Junk Bonds Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Junk Bonds Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Adimmune Stock Analysis

When running Adimmune Corp's price analysis, check to measure Adimmune Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adimmune Corp is operating at the current time. Most of Adimmune Corp's value examination focuses on studying past and present price action to predict the probability of Adimmune Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adimmune Corp's price. Additionally, you may evaluate how the addition of Adimmune Corp to your portfolios can decrease your overall portfolio volatility.